Biotech

All Articles

Life scientific research credit history agency introduces along with $600M

.A brand-new global life science credit scores agency, dubbed Symbiotic Capital, has reared much mor...

BMS ditches TIGIT, leaving $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing one more large wager coming from the Caforio age, canceling a package...

Nuvation standstills BET inhibitor after looking at period 1 information

.After having a look at stage 1 data, Nuvation Bio has actually chosen to halt work on its single to...

' Medical intuitiveness' led FDA advisors to back Zevra's unusual disease med

.Zevra Therapies' uncommon illness drug seems to be to be on the road to permission this loss after ...

Pfizer takes $230M reached after axing stopped working DMD genetics treatment

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene treatment failing has actually blown a $230...

AC Immune sees 'site' prospective in Alzheimer's drug records

.After much more than 20 years of work with neurodegenerative conditions, Swiss biotech air conditio...

GSK goes down ph. 2 HPV injection over lack of best-in-class possible

.GSK has actually junked a period 2 human papillomavirus (HPV) vaccine coming from its pipeline afte...

OS Therapies refiles $6M IPO to cash HER2 medicine, preclinical ADCs

.OS Therapies will note on the NYSE American sell substitution today via a $6.4 million IPO that the...

ALX's waning CD47 action rate sends out supply spiraling down

.ALX Oncology's stage 2 stomach cancer feedback price has actually weakened. After observing its own...

Ionis axes eye health condition coming from targets of Roche-partnered possibility after records let down

.An Additional of Ionis Pharmaceuticals' key midphase readouts has disappointed requirements, cuing ...